Qube Research & Technologies (QRT)
CALT

Qube Research & Technologies (QRT)’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$663 – 4322
2024
Q2 		$663 Sell
17
-55
-76% -$1.51K ﹤0.01% 3297
2024
Q1 		$1.56K Hold
72
– – ﹤0.01% 4013
2023
Q4 		$1.85K Hold
72
– – ﹤0.01% 3821
2023
Q3 		$1.31K Buy
+72
New +$1.25K ﹤0.01% 3613

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CALT Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 17 shares — an estimated $663 sold.

Qube Research & Technologies (QRT) first reported a position in CALT in Q3 2023 and held it in 4 quarters. The position peaked at $1.85K in Q4 2023. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 17 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $663.
  • Qube Research & Technologies (QRT) first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Calliditas Therapeutics AB American Depositary Shares position peaked at $1.85K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.